These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36378589)

  • 1. Meta-analysis of the diagnostic accuracy of serum type IV collagen 7S concentration for the staging of liver fibrosis in nonalcoholic fatty liver disease.
    Honda Y; Yoneda M; Kobayashi T; Iwaki M; Kawamura N; Nogami A; Kessoku T; Ogawa Y; Tomeno W; Imajo K; Horita N; Saito S; Kaneko T; Nakajima A
    Hepatol Res; 2023 Mar; 53(3):219-227. PubMed ID: 36378589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel rapid immunoassay of serum type IV collagen 7S for the diagnosis of fibrosis stage of nonalcoholic fatty liver diseases.
    Shima T; Ohtakaki Y; Kikuchi H; Uchino H; Isomura M; Aoyagi K; Oya H; Katayama T; Mitsumoto Y; Mizuno M; Umemura A; Yamaguchi K; Itoh Y; Okanoue T
    Hepatol Res; 2021 Mar; 51(3):263-276. PubMed ID: 33350036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Cao YT; Xiang LL; Qi F; Zhang YJ; Chen Y; Zhou XQ
    EClinicalMedicine; 2022 Sep; 51():101547. PubMed ID: 35844772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of Noninvasive Scoring Systems in Assessing Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Han S; Choi M; Lee B; Lee HW; Kang SH; Cho Y; Ahn SB; Song DS; Jun DW; Lee J; Yoo JJ
    Gut Liver; 2022 Nov; 16(6):952-963. PubMed ID: 35193993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).
    Yoneda M; Yoneda M; Mawatari H; Fujita K; Endo H; Iida H; Nozaki Y; Yonemitsu K; Higurashi T; Takahashi H; Kobayashi N; Kirikoshi H; Abe Y; Inamori M; Kubota K; Saito S; Tamano M; Hiraishi H; Maeyama S; Yamaguchi N; Togo S; Nakajima A
    Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wisteria floribunda agglutinin-positive Mac-2-binding protein and type 4 collagen 7S: useful markers for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease.
    Ogawa Y; Honda Y; Kessoku T; Tomeno W; Imajo K; Yoneda M; Kawanaka M; Kirikoshi H; Ono M; Taguri M; Saito S; Yamanaka T; Wada K; Nakajima A
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1795-1803. PubMed ID: 29633352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FibroScan-AST (FAST) Score for Nonalcoholic Steatohepatitis - Validation in an Indian Cohort.
    De A; Keisham A; Mishra S; Mehta M; Verma N; Premkumar M; Taneja S; Das A; Singh V; Duseja A
    J Clin Exp Hepatol; 2022; 12(2):440-447. PubMed ID: 35535068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-obese patients with nonalcoholic fatty liver disease may use a lower liver stiffness cut-off to assess fibrosis stages.
    Shi YW; Wang QY; Zhao XY; Sun YM; Kong YY; Ou XJ; Jia JD; Wu SS; You H
    J Dig Dis; 2020 May; 21(5):279-286. PubMed ID: 32336033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
    Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
    Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive Liver Fibrosis Tests in Patients with Nonalcoholic Fatty Liver Disease: An External Validation Cohort.
    Polyzos SA; Slavakis A; Koumerkeridis G; Katsinelos P; Kountouras J
    Horm Metab Res; 2019 Feb; 51(2):134-140. PubMed ID: 30273934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrosis in nonalcoholic fatty liver disease: Noninvasive assessment using computed tomography volumetry.
    Fujita N; Nishie A; Asayama Y; Ishigami K; Ushijima Y; Takayama Y; Okamoto D; Shirabe K; Yoshizumi T; Kotoh K; Furusyo N; Hida T; Oda Y; Fujioka T; Honda H
    World J Gastroenterol; 2016 Oct; 22(40):8949-8955. PubMed ID: 27833386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease.
    Sumida Y; Yoneda M; Hyogo H; Yamaguchi K; Ono M; Fujii H; Eguchi Y; Suzuki Y; Imai S; Kanemasa K; Fujita K; Chayama K; Yasui K; Saibara T; Kawada N; Fujimoto K; Kohgo Y; Okanoue T;
    J Gastroenterol; 2011 Feb; 46(2):257-68. PubMed ID: 20842510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of noninvasive scores for the detection of advanced fibrosis in patients with nonalcoholic fatty liver disease.
    Subasi CF; Aykut UE; Yilmaz Y
    Eur J Gastroenterol Hepatol; 2015 Feb; 27(2):137-41. PubMed ID: 25486027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
    Colli A; Nadarevic T; Miletic D; Giljaca V; Fraquelli M; Štimac D; Casazza G
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013346. PubMed ID: 33855699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopsy rate and nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD).
    Gerhardt F; Petroff D; Blank V; Böhlig A; van Bömmel F; Wittekind C; Berg T; Karlas T; Wiegand J
    Scand J Gastroenterol; 2020 Jun; 55(6):706-711. PubMed ID: 32476514
    [No Abstract]   [Full Text] [Related]  

  • 17. Value of intravoxel incoherent motion in detecting and staging liver fibrosis: A meta-analysis.
    Ye Z; Wei Y; Chen J; Yao S; Song B
    World J Gastroenterol; 2020 Jun; 26(23):3304-3317. PubMed ID: 32684744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy.
    Mikolasevic I; Domislovic V; Krznaric-Zrnic I; Krznaric Z; Virovic-Jukic L; Stojsavljevic S; Grgurevic I; Milic S; Vukoja I; Puz P; Aralica M; Hauser G
    Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208576
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic accuracy of combined biomarker measurements and vibration-controlled transient elastography (VCTE) for predicting fibrosis stage of non-alcoholic fatty liver disease.
    Shima T; Sakai K; Oya H; Katayama T; Mitsumoto Y; Mizuno M; Kanbara Y; Okanoue T
    J Gastroenterol; 2020 Jan; 55(1):100-112. PubMed ID: 31538241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative diagnostic accuracy of red cell distribution width-to-platelet ratio versus noninvasive fibrosis scores for the diagnosis of liver fibrosis in biopsy-proven nonalcoholic fatty liver disease.
    Cengiz M; Ozenirler S
    Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1293-9. PubMed ID: 26302023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.